Nyrada is an Australian publicly-listed (ASX: NYR) preclinical stage, drug development company. The Company specialises in the development of novel small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. The Company’s vision is to become a high growth pharmaceutical company specialising in drug discovery and early stage drug dev...
Nyrada is an Australian publicly-listed (ASX: NYR) preclinical stage, drug development company. The Company specialises in the development of novel small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. The Company’s vision is to become a high growth pharmaceutical company specialising in drug discovery and early stage drug development. The Company focuses on areas of substantial unmet clinical need and has identified drug candidates with significant therapeutic and commercial potential, where few if any, effective or well-tolerated therapies
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.